跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PEMETREXED SANDOZ pemetrexed (as disodium) 100 mg/4 mL concentrated solution for infusion vial - TGA Drug Approval Details
Approvals
/
TGA
/
PEMETREXED SANDOZ pemetrexed (as disodium) 100 mg/4 mL concentrated solution for infusion vial
Approved
STANDARD
PEMETREXED SANDOZ pemetrexed (as disodium) 100 mg/4 mL concentrated solution for infusion vial
Sandoz Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
0c78af8df5d18bb4
Company
Sandoz Pty Ltd
Type
Standard
Approval Details
Approval Id
0c78af8df5d18bb4
Product Name
PEMETREXED SANDOZ pemetrexed (as disodium) 100 mg/4 mL concentrated solution for infusion vial
Artg Id
393355
Artg Name
PEMETREXED SANDOZ pemetrexed (as disodium) 100 mg/4 mL concentrated solution for infusion vial
Sponsor
Sandoz Pty Ltd
Company Detail Path
/organization/sandoz-pty-ltd
Artg Date
2023-11-09
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
0c78af8df5d18bb4
Type
Standard
Back to TGA Approvals
